¾Ï ½ÃÀåÁ¶»çº¸°í¼­

¾ÏÄ¡·á °ü·Ã Á¶»çº¸°í¼­¿¡¼­´Â ±âÁ¸ ¶Ç´Â ½Å±Ô ¾ÏÁø´Ü ¹× Ä¡·á ¹æ¹ý¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶Ç ÀǾàǰ °³¹ß ÆÄÀÌÇÁ¶óÀÎ ¹× ƯÇã ½ÇÈ¿, »ç¾÷ Á¦ÈÞ, »õ·Î¿î Ä¡·á ¹æ½Ä, Ä¡·á Åø µîÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ·Â¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, 500°Ç ÀÌ»óÀÇ º¸°í¼­¸¦ ±¸ºñÇϰí ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 1,670°Ç)
MA(Medical Affairs) ÆòÆÇ(¹Ì±¹) - ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´
Medical Affairs Reputations (US) - Chronic Myeloid Leukemia
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 8,000 £Ü 11,154,000 (ºÎ°¡¼¼ º°µµ)
HER2-low ¾Ï - ½ÃÀå ±Ô¸ð, ´ë»ó ȯÀÚ, °æÀï ±¸µµ, ¿¹Ãø(2034³â)
HER2-low Cancers - Market Size, Target Population, Competitive Landscape, and Market Forecast-2034
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 7,950 £Ü 11,084,000 (ºÎ°¡¼¼ º°µµ)
Á¶Àý T ¼¼Æ÷(Tregs) - ½ÃÀå ±Ô¸ð, Ç¥Àû Àα¸, °æÀï ±¸µµ, ¿¹Ãø(2034³â)
Regulatory T cells (Tregs) - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 7,950 £Ü 11,084,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÆéŸÀÌµå ¾Ï ¹é½Å ½ÃÀå : ½ÃÀå ±âȸ, ±â¼ú Ç÷§Æû, ÀÓ»ó½ÃÇè µ¿Çâ(2030³â)
Global Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight 2030
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 3,000 £Ü 4,182,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾ÏÄ¡·á¿ë À¯ÀüüÇÐ ½ÃÀå º¸°í¼­(2025³â)
Genomics In Cancer Care Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý US $ 4,490 £Ü 6,260,000 (ºÎ°¡¼¼ º°µµ)
NPS+(¹Ì±¹) - Àü¸³¼±¾Ï
NPS+ (US) - Prostate Cancer
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 8,000 £Ü 11,154,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å×¶ó³ë½ºÆ½½º ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ¿ëµµ ºÐ¾ßº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
Theranostics Market by Product Type, Technology, Application Area, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
ÈÄµÎ¾Ï Ä¡·áÁ¦ ½ÃÀå : ºÐÀÚ À¯Çüº°, Åõ¿© °æ·Îº°, Ä¡·á À¯Çüº°, Á¦Çüº°, ¾Ï À¯Çüº°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Laryngeal Cancer Therapeutics Market by Molecule Type, Administration Route, Therapy Type, Dosage Form, Cancer Type, Distribution Channel, Application, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
Ç×¾ÏÁ¦ ½ÃÀå : ¾à¹° À¯Çü, Åõ¿© °æ·Î, Ä¡·á À¯Çü, ¾Ï À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, À¯Åë ä³Îº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Cancer Drugs Market by Drug Type, Administration Route, Therapy Type, Cancer Type, End User, Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
¹éÇ÷º´ Ä¡·áÁ¦ ½ÃÀå : À¯Çü, ÀÛ¿ë±â¼­, Ä¡·á ´Ü°è, Åõ¿© °æ·Î, ¿¬·ÉÃþ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Leukemia Therapeutics Market by Type, Mechanism of Action, Line of Therapy, Route of Administration, Age Group, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
µÎ°æºÎ¾Ï Ä¡·áÁ¦ ½ÃÀå : ¾à¹° Á¾·ùº°, Åõ¿© °æ·Îº°, ¾Ï À¯Çüº°, À¯Åë ä³Îº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Head & Neck Cancer Drugs Market by Drug Class, Route Of Administration, Cancer Type, Distribution Channel, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
½Å»ýÇ׿ø Ç¥ÀûÄ¡·á ½ÃÀå : Ä¡·á ¸ð´Þ¸®Æ¼, Ä¡·á Á¢±Ù, Åõ¿© °æ·Î, ¿¬·ÉÃþ, Ç¥Àû Áúȯ ÀûÀÀÁõ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Neoantigen Targeted Therapies Market by Therapy Modality, Treatment Approach, Route of Administration, Age Group, Target Disease Indication, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
¹úÅ© ÆÄŬ¸®Å¹¼¿ ½ÃÀå : °ø±Þ¿ø, Á¦Á¦ À¯Çü, ¼øµµ µî±Þ, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ÆÇ¸Å ä³Îº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Bulk Paclitaxel Market by Source, Formulation Type, Purity Grade, Application, End User, Sales Channel - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
ÆÛÅõÁÖ¸¿(Pertuzumab) ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Á¦, ¿ëµµ, À¯Åë ä³Î, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Pertuzumab Biosimilars Market by Formulation, Application, Distribution Channel, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 3,939 £Ü 5,492,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀýÁ¦ ºÒ°¡´É °£¼¼Æ÷¾Ï ½ÃÀå
Unresectable Hepatocellular Carcinoma
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å¹½ÃÆú¸° ½ÃÀå
Taxifolin
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °í¸³¼º ¼¶À¯Á¾ Ä¡·á ½ÃÀå
Solitary Fibrous Tumor Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °£¾Ï Ä¡·áÁ¦ ½ÃÀå
Liver Cancer Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ HER2 ¾ç¼º À§¾Ï ½ÃÀå
HER2-Positive Gastric Cancer
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ HER2 À¯¹æ¾Ï °Ë»ç ½ÃÀå
HER2 Breast Cancer Tests
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ À¯ÀüÀÚ ¾Ï ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå
Genetic Cancer Biomarkers
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºê·çŲ»ç ½ÃÀå
Brukinsa
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ¾Ï Ä¡·á ½ÃÀå
Pet Cancer Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼® - Á¦Ç° ¹× ¼­ºñ½ºº°, ±â¼úº°, ¾ÏÀÇ Áõ»óº°, ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Immuno Oncology Assays Market Size study & Forecast, by Product & Service, Technology, Cancer Indications, Application and Regional Forecasts 2022-2032
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 4,950 £Ü 6,901,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ½ÅÀå¾Ï Ä¡·á ¹× Áø´Ü ½ÃÀå
Kidney Cancer Therapeutics and Diagnostics
¹ßÇà 2025³â 08¿ù
°¡°Ý US $ 5,850 £Ü 8,156,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.